Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Wickes Group (WIX) by Harvey Jones in The Motley Fool
- Neutral Burberry Group (BRBY) by UBS
- Watch Johnson Matthey (JMAT) by Harvey Jones in The Motley Fool
- Hold Direct Line Insurance Group (DLG) by Berenberg
- Buy National Grid (NG.) by Simon Watkins in The Motley Fool
- Buy National Grid (NG.) by Bank of America
- Hold Currys (CURY) by Deutsche Bank
- Buy Great Portland Estates (GPE) by Goldman Sachs
- Buy Tate & Lyle (TATE) by Berenberg
- Sector Perform Ceres Power Holdings (CWR) by RBC Capital
- Avoid Lloyds Banking Group (LLOY) by Royston Wild in The Motley Fool
- Buy Persimmon (PSN) by Citi
- Outperform Ashtead Group (AHT) by RBC Capital
- Overweight easyJet (EZJ) by Barclays
- Neutral Oxford Biomedica (OXB) by JP Morgan
- Overweight Hikma Pharmaceuticals (HIK) by JP Morgan
- Buy easyJet (EZJ) by UBS
- Speculative Buy Spirent Communications (SPT) by Canaccord Genuity
- Buy Volution Group (FAN) by Berenberg
- Buy PensionBee Group (PBEE) by Canaccord Genuity
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 58 open tips for Avacta Group (AVCT)
| Latest Bid : 47.00p | Latest Ask : 49.00p |
| High Today : 50.50p | Low Today : 46.80p |
| This Years High : 135.00p | This Years Low : 39.75p |
| Volume : 1,117,749 | MKT Cap : £177.12M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | 15.79% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 29.41% |
| Sell | Tom Winnifrith | Premium Only | 2024-06-26 09:30:00 26/06/2024 | -6.67% |
| Hold | Deutsche Bank | Premium Only | 2024-06-19 07:24:00 19/06/2024 | 70.00% |
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 12.09% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| GSA Capital Partners LLP | 0.78% | 10/07/2024 |
| Latest Bid : 47.00p | Latest Ask : 49.00p |
| High Today : 50.50p | Low Today : 46.80p |
| This Years High : 135.00p | This Years Low : 39.75p |
| Volume : 1,117,749 | MKT Cap : £177.12M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-09-17 10:35:00 17/09/2024 | 15.79% |
| Sell | Deutsche Bank | Premium Only | 2024-09-17 07:27:00 17/09/2024 | 29.41% |
| Sell | Tom Winnifrith | Premium Only | 2024-06-26 09:30:00 26/06/2024 | -6.67% |
| Hold | Deutsche Bank | Premium Only | 2024-06-19 07:24:00 19/06/2024 | 70.00% |
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 12.09% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000